In ovarian cancer, DOT1L has been shown to promote tumor growth by associating with estrogen receptor alpha to regulate cell cycle progression, epithelial–mesenchymal transition, drug metabolism, and cell-to-cell signaling [18,19,]. Here, DOT1L is linked to ovarian cancer.